HEALTHCARE SERVICES GROUP (HCSG) Company Report

HCSG reported Q3 2025 revenue of $464.3 million, an 8.5% increase over the prior year, with net income of $43 million and diluted earnings per share of $0.59.
The company estimates Q4 revenue to be in the range of $460 million to $470 million and expects to manage SG&A in the 9.5% to 10.5% range in the near term.
Cash flow from operations was $71.3 million, including a $31.8 million benefit related to ERC receipts, contributing to a strong balance sheet with $207.5 million in cash and marketable securities at quarter-end.
HCSG repurchased $27.3 million of common stock in Q3, bringing year-to-date buybacks to $42 million under a $50 million share repurchase plan valid through June 2026.
Strategic priorities for Q4 include driving growth, managing costs, and optimizing cash flow, while the company continues to service Genesis facilities without operational disruption during their bankruptcy process.

Oct 22, 2025, 12:30 PM

Transcript

HCSG Reports Strong Q3 2025 Revenue Growth and Positive Earnings Impact from ERC

HCSG

Earnings

Guidance Update

Share Buyback

M&A

Healthcare Services Group (HCSG) reported Q3 2025 revenue of $464.3 million, an 8.5% increase year-over-year, and anticipates Q4 2025 revenue between $460 million and $470 million.
Diluted earnings per share were $43.59 in Q3 2025, benefiting from a $0.36 per share impact primarily related to the Employee Retention Credit (ERC).
The company maintained a strong balance sheet with $207.5 million in cash and marketable securities at quarter-end and executed $27.3 million in common stock repurchases during Q3, totaling $42 million year-to-date.
Strategic priorities for Q4 2025 focus on driving growth through new client wins and retention, cost management, and cash flow optimization, with the "campus initiative" identified as the primary target for future acquisitions.
HCSG noted a strong labor market with stabilized wage growth and record application levels, and confirmed continued service provision to Genesis Healthcare facilities amidst their bankruptcy process.

Oct 22, 2025, 12:30 PM

Transcript

Healthcare Services Group, Inc. Reports Strong Q3 2025 Results

HCSG

Earnings

Revenue Acceleration/Inflection

Share Buyback

Healthcare Services Group, Inc. reported revenue of $464.3 million for the three months ended September 30, 2025, marking an 8.5% increase over the prior year.
Net income was $43.0 million and diluted EPS was $0.59 for Q3 2025, which included a $0.361 benefit primarily related to the Employee Retention Credit (ERC).
Cash flow from operations totaled $71.3 million, or $87.1 million excluding the change in payroll accrual, with a $31.8 million benefit related to the ERC.
The company maintained strong liquidity with $207.5 million in cash and marketable securities as of September 30, 2025, and repurchased $27.3 million of common stock during the quarter.

Oct 22, 2025, 11:02 AM

8-K

HCSG Reports Third Quarter 2025 Results

HCSG

Earnings

Share Buyback

Revenue Acceleration/Inflection

Healthcare Services Group (HCSG) reported third quarter 2025 revenue of $464.3 million, an 8.5% increase over the prior year, with net income of $43.0 million and diluted EPS of $0.59.
The diluted EPS includes a $0.361 benefit primarily related to the Employee Retention Credit (ERC), which also contributed a $31.8 million benefit to cash flow from operations.
Cash flow from operations for the quarter was $71.3 million, or $87.1 million excluding the change in payroll accrual.
The company repurchased $27.3 million of its common stock during the third quarter under its $50.0 million share repurchase plan.
As of September 30, 2025, HCSG had cash and marketable securities totaling $207.5 million.

Oct 22, 2025, 11:00 AM

Press Release

Healthcare Services Group Inc. Reports Q2 2025 Results, Updates 2025 Guidance, and Announces Share Repurchase Plan

HCSG

Earnings

Guidance Update

Share Buyback

Healthcare Services Group Inc. reported Q2 2025 revenue of $458.5 million, a 7.6% increase over the prior year, marking its fifth consecutive sequential revenue increase.
The company incurred a net loss of $32.4 million, or $0.44 per share, primarily due to a $61.2 million non-cash charge related to the Genesis Healthcare restructuring, with an additional $0.04 per share charge expected in Q3 2025.
HCSG reiterated its 2025 mid-single-digit growth expectations and raised its 2025 cash flow from operations forecast (excluding payroll accrual changes) from $60-$70 million to $75-$85 million.
The company announced plans to repurchase an additional $50 million of common stock over the next twelve months, having already repurchased $14.6 million year-to-date.

Jul 24, 2025, 11:30 AM

Healthcare Services Group Inc Annual 8-K Shareholder Meeting Outcomes

HCSG

Proxy Vote Outcomes

Auditor Change

Board Change

The 8-K filing from Q1 2025 details the annual shareholder meeting held on May 27, 2025, with a record date of March 31, 2025 and approximately 72.9 million shares outstanding.
Shareholders approved the election of nine directors and voted on key proposals including the Say on Pay resolution and ratification of Grant Thornton LLP as the independent auditor.

May 28, 2025, 12:00 AM

8-K

HCSG Q1 2025 Earnings & Financial Highlights

HCSG

Earnings

M&A

Share Buyback

Guidance Update

Revenue Acceleration/Inflection

Revenue reached $447.7 million, up 5.7% YoY with net income of $17.2 million and diluted EPS of $0.23.
Adjusted cash flow from operations totaled $32.1 million – best in five years – with DSO shortened from 88 to 78 days.
Strong liquidity position reported with $143.9 million in cash and marketable securities and an undrawn $500 million credit facility.
Solid segment performance with Environmental Services at $196.3 million (10.8% margin) and Dietary Services at $251.3 million (7.6% margin).
Strategic initiatives include Q2 revenue guidance of $445–$455 million, a tuck-in acquisition contributing ~1% to revenue, and ongoing opportunistic share buybacks ($7 million repurchased in Q1).
Raised cash flow forecast for 2025 to $60.0–$75.0 million and reiterated mid-single-digit revenue growth guidance.

Apr 23, 2025, 12:31 PM

Transcript 8-K

Healthcare Services Group Reports Q4 2024 Results

HCSG

Earnings

Revenue Acceleration/Inflection

Guidance Update

Q4 2024 results: Reported revenue of $437.8 million, net income of $11.9 million, and diluted EPS of $0.16.
Cash flow performance: Generated $36.2 million from operations (or $27.0 million excluding payroll accrual) in Q4.
2025 outlook: Projects Q1 revenue between $440.0–$450.0 million with targeted actual cash flows of $45.0 to $60.0 million.
Strategic priorities: Focus on managing cost efficiency (targeting 86% cost of services and SG&A within 8.5–9.5%), driving organic growth through new business additions, and expanding service offerings.
Liquidity & retention: Maintains strong liquidity with $135.8 million in cash/marketable securities and a $500 million credit facility, while client retention exceeded 90%.

Feb 12, 2025, 12:00 AM

Transcript 8-K

Earnings Transcripts

Quarterly earnings call transcripts for HEALTHCARE SERVICES GROUP.

Ask Fintool AI Agent

Get instant answers from SEC filings, earnings calls & more

What did Theodore Wahl say about margins?What are HEALTHCARE SERVICES GROUP's strategic priorities?How is HEALTHCARE SERVICES GROUP positioned vs competitors?How did HEALTHCARE SERVICES GROUP do last quarter?

Let Fintool AI Agent track HEALTHCARE SERVICES GROUP's earnings for you

Get instant analysis when filings drop